Vaccine Myths: Setting the Record Straight

Despite their standing as one of the most remarkable public health achievements, vaccines have been surrounded by dangerous myths since the development of the smallpox vaccine in the 18th century. In recent decades, with the publication of a fraudulent article linking vaccines to autism, the involvement of celebrities in the debate, and the rise of the internet and social media as sources for information for patients, these myths have become more widespread. This paper reviews four common vaccine myths: vaccines cause autism, vaccines are not safe, too many vaccines are given too soon, and the influenza vaccine is not necessary. For each of these myths, we review the origin and spread of misinformation. The authors then present the scientific evidence against each myth. Extensive research has found no link between vaccines, and particularly the MMR vaccine or the preservative thimerosal, and autism. The U.S. and world health agencies have effective mechanisms in place to review and monitor vaccine safety. These systems have worked to detect and evaluate even rare vaccine adverse events. The recommended vaccine schedule is safe for infants’ immune systems. The flu vaccine is an essential tool in the fight against the seasonal influenza deaths. A consequence of these myths is that parents are choosing to delay or refuse recommended vaccines for themselves and their children. This has resulted in outbreaks of measles, pertussis, H. influenza type b, varicella, and pneumococcal disease in the United States. Unvaccinated and undervaccinated children risk contracting the disease themselves, and pose a risk to their community as herd immunity decreases. It is important to explore and refute the myths leading to decreased vaccination rates, so health care providers and parents can make educated decisions to protect children and ensure public health

Integrated stratigraphical study of the Rhuddanian-Aeronian (Llandovery, Silurian) boundary succession in the Rheidol Gorge, Wales:A proposed Global Stratotype Section and Point for the base of the Aeronian Stage

The Rheidol Gorge section, approximately 17 km east of Aberystwyth, mid Wales, exposes a ca. 20 m-thick succession of Llandovery (Silurian) strata from the upper Rhuddanian Pernerograptus revolutus Biozone through the lower Aeronian Demirastrites triangulatus Biozone and basal Neodiplograptus magnus Biozone. The section records deposition under a range of bottom-water oxygenation states. The Rhuddanian-Aeronian boundary is located 0.8 m above an abrupt lithological change from predominantly organic-poor, bioturbated `oxic' mudrocks to an interval of black, richly graptolitic `anoxic' shales. The graptolite fauna through the boundary interval, including the local lowest occurrence of D. triangulatus, allows precise correlation with other parts of the world. Graptolite assemblages indicative of separate divisions in the underlying revolutus Biozone and of the lower and upper parts of the triangulatus Biozone are also present. Chitinozoans are relatively well preserved in the section and indicate the Spinachitina maennili Biozone throughout the boundary interval, as is widely the case. The results of carbon isotope analyses from organic matter indistinctly show the weak interval of positive shift in d13C org values through the Rhuddanian-Aeronian boundary interval, as observed globally, though local or regional processes appear largely to overprint the global signal. Overall, the excellent biostratigraphical record, well-documented local and regional stratigraphical context, historical significance, as well as easy access and assured longterm preservation, mean that the Rheidol Gorge section can be proposed as a strong candidate for a new Global Stratotype Section and Point for the base of the Aeronian Stage.. Silurian, Llandovery, Rhuddanian, Aeronian, Global Stratotype Section and Point, Graptolites, Chitinozoa, Carbon Isotope

Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19–Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance — 20 States, March 9, 2022–May 31, 2023

Infants aged <6 months are not eligible for COVID-19 vaccination. Vaccination during pregnancy has been associated with protection against infant COVID-19–related hospitalization. The Overcoming COVID-19 Network conducted a case-control study during March 9, 2022–May 31, 2023, to evaluate the effectiveness of maternal receipt of a COVID-19 vaccine dose (vaccine effectiveness [VE]) during pregnancy against COVID-19–related hospitalization in infants aged <6 months and a subset of infants aged <3 months. VE was calculated as (1 – adjusted odds ratio) x 100% among all infants aged <6 months and <3 months. Case-patients (infants hospitalized for COVID-19 outside of birth hospitalization and who had a positive SARS-CoV-2 test result) and control patients (infants hospitalized for COVID-19–like illness with a negative SARS-CoV-2 test result) were compared. Odds ratios were determined using multivariable logistic regression, comparing the odds of receipt of a maternal COVID-19 vaccine dose (completion of a 2-dose vaccination series or a third or higher dose) during pregnancy with maternal nonvaccination between case- and control patients. VE of maternal vaccination during pregnancy against COVID-19–related hospitalization was 35% (95% CI = 15%–51%) among infants aged <6 months and 54% (95% CI = 32%–68%) among infants aged <3 months. Intensive care unit admissions occurred in 23% of all case-patients, and invasive mechanical ventilation was more common among infants of unvaccinated (9%) compared with vaccinated mothers (1%) (p = 0.02). Maternal vaccination during pregnancy provides some protection against COVID-19–related hospitalizations among infants, particularly those aged <3 months. Expectant mothers should remain current with COVID-19 vaccination to protect themselves and their infants from hospitalization and severe outcomes associated with COVID-19

TRY plant trait database – enhanced coverage and open access

Plant traits - the morphological, anatomical, physiological, biochemical and phenological characteristics of plants - determine how plants respond to environmental factors, affect other trophic levels, and influence ecosystem properties and their benefits and detriments to people. Plant trait data thus represent the basis for a vast area of research spanning from evolutionary biology, community and functional ecology, to biodiversity conservation, ecosystem and landscape management, restoration, biogeography and earth system modelling. Since its foundation in 2007, the TRY database of plant traits has grown continuously. It now provides unprecedented data coverage under an open access data policy and is the main plant trait database used by the research community worldwide. Increasingly, the TRY database also supports new frontiers of trait‐based plant research, including the identification of data gaps and the subsequent mobilization or measurement of new data. To support this development, in this article we evaluate the extent of the trait data compiled in TRY and analyse emerging patterns of data coverage and representativeness. Best species coverage is achieved for categorical traits - almost complete coverage for ‘plant growth form’. However, most traits relevant for ecology and vegetation modelling are characterized by continuous intraspecific variation and trait–environmental relationships. These traits have to be measured on individual plants in their respective environment. Despite unprecedented data coverage, we observe a humbling lack of completeness and representativeness of these continuous traits in many aspects. We, therefore, conclude that reducing data gaps and biases in the TRY database remains a key challenge and requires a coordinated approach to data mobilization and trait measurements. This can only be achieved in collaboration with other initiatives

How does a cross-grade tutoring program impact organization and homework completion of two disorganized sixth grade students

This case study researched the effects of a cross-grade tutoring program involving high school students and two sixth grade students. Two high school students and two 6th grade students took part in the case study. The ultimate goal of the program was to see if teaching organizational skills and time management skills would increase organization and decrease the amount of late work. The results of the study suggest: 1) that students benefit from additional attention given by an older person 2) increased opportunities for more assistance throughout the school day for struggling students. The results of the study showed that students need help outside of school and many times the parents don\u27t have time to give it to the students so the schools need to be providing some assistance to these at-risk students

The effect of screening for vaccine hesitancy on the subsequent development of hesitancy: a randomized controlled trial, Houston, TX

Vaccine hesitancy remains a global health threat. Addressing parental vaccine hesitancy is essential to maintaining high vaccine coverage levels and preventing disease outbreaks; however, it is unknown if administering a vaccine hesitancy screening tool negatively impacts parental vaccine beliefs. We conducted a stratified randomized controlled trial in pediatric primary care practices. English-speaking parents ≥18 years of age seeking routine care for infants <3 months of age were eligible. Participants were randomized to receive 1 of 2 surveys – the Parent Attitudes about Childhood Vaccines (PACV) survey or a placebo survey. Six months after initial enrollment, all participants were asked to complete the PACV, regardless of initial randomization group. Our primary outcome was the proportion of hesitant to non-hesitant parents at 6-months between randomization groups. We examined associations between vaccine hesitancy and participant characteristics. We also evaluated the change in the proportion of vaccine-hesitant parents in the PACV group between baseline and 6-month follow up. We enrolled 1705 parents at baseline. At 6-month follow up, 819 parents completed the PACV (50.2% from PACV group vs. 54.1% from placebo group). The proportion of hesitant parents at 6 months did not differ between PACV and placebo groups (6.6% vs. 6.1%; p = .78) and the odds of hesitancy among PACV group participants was not higher than those in the placebo group (OR = 1.10; 95% CI: 0.63–1.93; p = .743). Race was the only characteristic significantly associated with vaccine hesitancy at 6-month follow up (p = .003). Overall, administration of the PACV did not trigger vaccine hesitancy in this study population

Development of a Spanish version of the parent attitudes about childhood vaccines survey

The Parent Attitudes about Childhood Vaccines (PACV) survey is a validated instrument for identifying vaccine-hesitant parents; however, a Spanish version is not available. Utilizing the WHO framework for translating survey instruments, we used an iterative process for developing the Spanish PACV that included forward translation, expert panel review, back translation and pre-testing that utilized cognitive interviewing. We made revisions to the Spanish PACV at each step, focusing on addressing inclusivity, readability, clarity and conceptual equivalence. The expert panel was comprised of 6 Spanish-speaking medical and research professionals who worked alongside 3 study team members. Pre-testing was conducted using convenience sampling of Spanish-speaking parents (N = 35) who had a child receiving care at the residents’ continuity clinic at Texas Children’s Hospital. Most pre-testing participants were married (80.6%), mothers (97.1%), ≥30 years of age (88.2%) and had a high school education or less (70.6%). While the majority of participants stated the survey was easy to complete, the translation of 5 PACV items was further revised to improve interpretability. We conclude that the final Spanish PACV is conceptually equivalent and culturally appropriate for most Hispanic populations